SCHEMBL2383382

SCHEMBL2383382

COc1c(-c2ccc(CN3CCNCC3)cc2)ccc2c(=O)c3c(=O)[nH]sc3n(C3CC3)c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.41
AURKA O14965 1/20 0.41
CHUK O15111 1/20 0.41
MAPK13 O15264 1/20 0.41
DAPK3 O43293 1/20 0.41
PRKCG P05129 1/20 0.41
PIM1 P11309 1/20 0.41
CDK2 P24941 1/20 0.41
MARK3 P27448 1/20 0.41
AKT1 P31749 1/20 0.41
AKT2 P31751 1/20 0.41
MAPKAPK2 P49137 1/20 0.41
GSK3A P49840 1/20 0.41
NEK2 P51955 1/20 0.41
PLK1 P53350 1/20 0.41
MAPK12 P53778 1/20 0.41
CDK5 Q00535 1/20 0.41
PRKCD Q05655 1/20 0.41
PAK1 Q13153 1/20 0.41
STK3 Q13188 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL589961 0.92 IKBKB (0.41) IKBKBAURKACHUKMAPK13DAPK3
SCHEMBL12250253 0.87
SCHEMBL590844 0.87 IKBKB (0.45) IKBKBAURKACHUKMAPK13DAPK3
Hydrochloric Acid SCHEMBL2382140 0.86
SCHEMBL2382135 0.86 IKBKB (0.44) IKBKBAURKACHUKMAPK13DAPK3
SCHEMBL2385588 0.84 IKBKB (0.42) IKBKBAURKACHUKMAPK13DAPK3
SCHEMBL12250242 0.84 IKBKB (0.42) IKBKBAURKACHUKMAPK13DAPK3
SCHEMBL3389481 0.82
SCHEMBL12250218 0.81
Hydrochloric Acid SCHEMBL2383294 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664062-B1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS INC (US) 2013-03-13 EP claimed
US-20110223132-A1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS, INC. (US) 2011-09-15 US claimed
US-20050075363-A1 Isothiazoloquinolones and related compounds as anti-infective agents ACHILLION PHARMACEUTICALS, INC. 2005-04-07 US claimed
EP-1664062-B1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS INC (US) 2013-03-13 EP disclosed
US-20110223132-A1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS, INC. (US) 2011-09-15 US disclosed
US-20110223132-A1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS, INC. (US) 2011-09-15 US disclosed
US-20110223132-A1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS ACHILLION PHARMACEUTICALS, INC. (US) 2011-09-15 US disclosed
US-20050075363-A1 Isothiazoloquinolones and related compounds as anti-infective agents ACHILLION PHARMACEUTICALS, INC. 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075363-A1 Isothiazoloquinolones and related compounds as anti-infective agents TOP1, IRF3, RECQL IKBKB 335/4885AURKA 867/4885CHUK 137/4885
US-20110223132-A1 ISOTHIAZOLOQUINOLONES AND RELATED COMPOUNDS AS ANTI-INFECTIVE AGENTS TOP1, IRF3, RECQL IKBKB 317/4885AURKA 785/4885CHUK 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.